Project 2 takes an integrated, molecular approach to understanding modifiable factors for colorectal cancer (CRC) risk and survival. A number of factors (metabolism, energy balance, aspirin, vitamin D) have been associated with CRC risk, and substantial intersections exist between nutrient excess, derangements in cellular and molecular mediators of inflammation, and vitamin D insufficiency, which jointly appear to drive CRC development and progression. Nonetheless, there remains a critical need to further investigate these interventions before clinical translation. We will leverage the resources of 3 unique and rich study populations to pursue innovative conceptual and technical approaches, which have not been or only rarely used to date to study CRC. Specifically, using two large cohorts of women (NHS) and men (HPFS) with >35 years of follow- up, we will examine underlying mechanistic pathways by incorporating metabolomic profiles, tumoral gene expression and whole exome sequencing data to understand and further define strategies for improving CRC prevention and treatment. Beyond our hypothesis-based work, we will further leverage these innovative and novel platforms to systemically identify new targets for prevention and therapy. Moreover, building on our extensive published observational work in these cohorts assessing the role of vitamin D in colorectal carcinogenesis, we will now examine the influence of vitamin D supplementation on risk of colorectal adenoma within a large, placebo-controlled randomized clinical trial (RCT; the VITAL study), which oversampled for African-Americans due to their higher prevalence of vitamin D deficiency. Finally, among NHS and HPFS participants diagnosed with CRC, we will examine the relation of these modifiable factors to survival following CRC treatment. We are uniquely positioned to address these critical research questions in these well- established study cohorts with long-term follow-up, archived blood and tissue specimens, a validated metabolomics platform, and the ability to evaluate post-diagnostic exposures while controlling for pre- diagnostic behaviors. Findings from this novel, comprehensive investigation will substantially enhance our understanding of CRC etiology, its molecular subtypes, and survival. Identifying modifiable factors to improve CRC survival has potential translational implications through changes in clinical recommendations. Together with Projects 1, 3, and 4, our aims also will identify etiology and prevention for 3 of the top 5 causes of cancer death.

Public Health Relevance

PROGRAM NARRATIVE Project 2 takes an integrated, molecular approach to understanding modifiable factors for colorectal cancer (CRC) risk and survival. Findings from this novel, comprehensive investigation will substantially enhance our understanding of CRC etiology, its molecular subtypes, and survival.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA087969-17
Application #
9149478
Study Section
Special Emphasis Panel (ZCA1-RPRB-B)
Program Officer
Mahabir, Somdat
Project Start
Project End
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
17
Fiscal Year
2016
Total Cost
$421,096
Indirect Cost
$87,895
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Graff, Rebecca E; Cho, Eunyoung; Preston, Mark A et al. (2018) Dietary Acrylamide Intake and Risk of Renal Cell Carcinoma in Two Large Prospective Cohorts. Cancer Epidemiol Biomarkers Prev 27:979-982
Marinac, Catherine R; Birmann, Brenda M; Lee, I-Min et al. (2018) Body mass index throughout adulthood, physical activity, and risk of multiple myeloma: a prospective analysis in three large cohorts. Br J Cancer 118:1013-1019
Zong, Geng; Valvi, Damaskini; Coull, Brent et al. (2018) Persistent organic pollutants and risk of type 2 diabetes: A prospective investigation among middle-aged women in Nurses' Health Study II. Environ Int 114:334-342
Houghton, Lauren C; Sisti, Julia S; Hankinson, Susan E et al. (2018) Estrogen Metabolism in Premenopausal Women Is Related to Early Life Body Fatness. Cancer Epidemiol Biomarkers Prev 27:585-593
Hagan, Kaitlin A; Erekson, Elisabeth; Austin, Andrea et al. (2018) A prospective study of the natural history of urinary incontinence in women. Am J Obstet Gynecol 218:502.e1-502.e8
Cook, Erin E; Gershman, Susan T; Kim, Jane J et al. (2018) Trends of two HPV-associated cancers in Massachusetts: cervical and oropharyngeal cancer. Cancer Causes Control 29:435-443
Grasso, Catherine S; Giannakis, Marios; Wells, Daniel K et al. (2018) Genetic Mechanisms of Immune Evasion in Colorectal Cancer. Cancer Discov 8:730-749
Hamada, Tsuyoshi; Khalaf, Natalia; Yuan, Chen et al. (2018) Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer. Clin Gastroenterol Hepatol 16:1300-1306.e3
Beattie, J Renwick; Feskanich, Diane; Caraher, M Clare et al. (2018) A Preliminary Evaluation of the Ability of Keratotic Tissue to Act as a Prognostic Indicator of Hip Fracture Risk. Clin Med Insights Arthritis Musculoskelet Disord 11:1179544117754050
Theofylaktopoulou, Despoina; Midttun, Øivind; Ueland, Per M et al. (2018) Impaired functional vitamin B6 status is associated with increased risk of lung cancer. Int J Cancer 142:2425-2434

Showing the most recent 10 out of 1708 publications